• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN PUMP; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN PUMP; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 14000
Device Problem Insufficient Information (3190)
Patient Problems Dehydration (1807); Hyperglycemia (1905); Nausea (1970); Virus (2136); Vomiting (2144); Diabetic Ketoacidosis (2364)
Event Date 06/16/2020
Event Type  malfunction  
Manufacturer Narrative
According to the complainant the device will not be returned for investigation.We are unable to determine if any product condition could have contributed to the reported hospitalization and diabetic ketoacidosis.No lot release records were reviewed, as the product lot number was not provided.For your reference, insulet modified our internal investigation finding codes effective 25 may 2020 as part of an effort to improve the classification of findings to improve the power of trending data and make the findings more intuitive.The new findings codes will use the system of finding category (e.G.Hardware component), followed by the affected component (e.G.Needle), followed by the condition (e.G.Bent).Therefore you may notice findings that appear to be new or different but in fact are just renamed for improved data value.Insulet would be happy to explain any mapping of the old to new finding codes if you have any questions.
 
Event Description
"it was reported that the patient had been hospitalized with diabetic ketoacidosis (dka).The patient's blood glucose levels rose from 328 mg/dl to 366 mg/dl while wearing the pod longer than 48 hours.Symptoms reported include hyperglycemia, nausea, vomiting and dehydration; high ketones were also present.Patient was admitted to the intensive care unit (icu) the pod was removed and patient was treated with an insulin drip, potassium, magnesium and zofran for vomiting; she was also prescribed zofran (4 mg) for an unknown period of time.The patient was released after spending 2 days in the hospital.Patient also reported having a stomach virus.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN PUMP
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
jordan biswurm
100 nagog park
acton, MA 01720
9786007000
MDR Report Key10235633
MDR Text Key198939995
Report Number3004464228-2020-10766
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385081120002
UDI-Public(01)20385081120002
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K122953
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 06/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number14000
Device Catalogue NumberZXP425
Was Device Available for Evaluation? No
Date Manufacturer Received06/24/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age25 YR
-
-